Prussian Blue Therapy
Prussian Blue Therapy is a medical treatment modality that employs the administration of Prussian blue, a ferric hexacyanoferrate compound, to enhance the elimination of thallium through enterohepatic recirculation interruption by binding thallium in the gastrointestinal tract.
171
Publications
9.7K
Citations
1.1K
Authors
331
Institutions
Publications per year
2017–2026
108
Variants
Prussian Blue Treatment
Parents
171
Prussian Blue Nanozyme as a Pyroptosis Inhibitor Alleviates Neurodegeneration
Xinxin Ma, Junnian Hao, Jianrong Wu et al. · Advanced Materials · 2022 · 244 citations
1–5 of 171
1.1K
10
h-index
7
h-index
7
h-index
6
h-index
5
h-index
1–5 of 1.1K
331

Chinese Academy of Sciences
Beijing, China
13 h-index
53 publications
6.6K citations

Shanghai Jiao Tong University
Shanghai, China
11 h-index
55 publications
6.2K citations
Shanghai Sixth People's Hospital
Shanghai, China
9 h-index
35 publications
4.5K citations
George Washington University
Washington, United States
7 h-index
32 publications
2.2K citations

Hunan University
Changsha, China
6 h-index
34 publications
2.6K citations
Anhui Medical University
Hefei, China
5 h-index
8 publications
402 citations
Tongji University
Shanghai, China
5 h-index
22 publications
1.9K citations

Southeast University
Nanjing, China
5 h-index
34 publications
1.8K citations
1–8 of 331
9 publications · 346 citations
9
h-index
7 publications · 189 citations
7
h-index
7 publications · 165 citations
7
h-index
7 publications · 723 citations
7
h-index
Repository · 6 publications · 179 citations
6
h-index
1–5